BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6122854)

  • 1. Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity.
    Jung RT; Campbell RG; James WP; Callingham BA
    Lancet; 1982 May; 1(8280):1043-6. PubMed ID: 6122854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hypothalamic control of prolactin secretion in massive obesity.
    Kopelman PG; White N; Pilkington TR; Jeffcoate SL
    Lancet; 1979 Apr; 1(8119):747-50. PubMed ID: 85990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
    Kopelman PG; Noonan K; Goulton R; Forrest AJ
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.
    Papalia D; Lunetta M; Di Mauro M
    J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired prolactin secretion and body fat distribution in obesity.
    Weaver JU; Noonan K; Kopelman PG; Coste M
    Clin Endocrinol (Oxf); 1990 May; 32(5):641-6. PubMed ID: 2194712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of insulin- and proinsulin-induced hypoglycemia on pituitary hormone and catecholamine secretion.
    Williams TC; Berelowitz M; Berk MA; Frohman LA
    Diabetes Care; 1987; 10(3):278-85. PubMed ID: 3109862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for existence of two types of massive obesity.
    Kopelman PG; Pilkington TR; White N; Jeffcoate SL
    Br Med J; 1980 Jan; 280(6207):82-3. PubMed ID: 6986184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to insulin induced hypoglycaemia in lean and obese subjects.
    Swaminathan R; Anderson E; Dean H; Wales JK
    Horm Metab Res; 1986 Jan; 18(1):45-8. PubMed ID: 3512395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and growth hormone response in induced hypoglycaemia in obese patients.
    Micić DD; Djurić DS; Manojlović DL; Dragasević MM
    Endocrinologie; 1981; 19(2):137-41. PubMed ID: 7020062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of enkephalin analogue on pituitary hormone release in human obesity.
    Finer N; Price P; Grossman A; Besser GM
    Horm Metab Res; 1987 Feb; 19(2):68-70. PubMed ID: 3104184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired prolactin secretion in obese patients.
    Cavagnini F; Maraschini C; Pinto M; Dubini A; Polli EE
    J Endocrinol Invest; 1981; 4(2):149-53. PubMed ID: 6792262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction.
    Kopelman PG; Pilkington TR; Jeffcoate SL; White N
    Br Med J; 1980 Aug; 281(6236):358-9. PubMed ID: 6775739
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.
    Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K
    J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents.
    Eliakim A; Nemet D; Zaldivar F; McMurray RG; Culler FL; Galassetti P; Cooper DM
    J Appl Physiol (1985); 2006 May; 100(5):1630-7. PubMed ID: 16373448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, prolactin, and corticosteroid responses to insulin hypoglycaemia in alcoholics.
    Chalmers RJ; Bennie EH; Johnson RH; Masterton G
    Br Med J; 1978 Mar; 1(6115):745-8. PubMed ID: 630327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma.
    Schöfl C; Schleth A; Berger D; Terkamp C; von zur Mühlen A; Brabant G
    J Clin Endocrinol Metab; 2002 Feb; 87(2):624-9. PubMed ID: 11836295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation in the response of plasma prolactin, cortisol, and growth hormone to insulin-induced hypoglycemia in normal men.
    Nathan RS; Sachar EJ; Langer G; Tabrizi MA; Halpern FS
    J Clin Endocrinol Metab; 1979 Aug; 49(2):231-5. PubMed ID: 572373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.